These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2128028)

  • 21. Systemic scleroderma. Multicenter trial of 1 year of treatment with recombinant interferon gamma.
    Hunzelmann N; Anders S; Fierlbeck G; Hein R; Herrmann K; Albrecht M; Bell S; Thur J; Muche R; Adelmann-Grill B; Wehner-Caroli J; Gaus W; Krieg T
    Arch Dermatol; 1997 May; 133(5):609-13. PubMed ID: 9158414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Placebo controlled trial of methotrexate in systemic sclerosis.
    Das SN; Alam MR; Islam N; Rahman MH; Sutradhar SR; Rahman S; Khan GK; Rahim A; Haq SA
    Mymensingh Med J; 2005 Jan; 14(1):71-4. PubMed ID: 15695960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methotrexate has no antifibrotic effect in bleomycin-induced experimental scleroderma.
    Ozgen M; Koca SS; Isik A; Ozercan IH
    J Rheumatol; 2010 Mar; 37(3):678-9. PubMed ID: 20197571
    [No Abstract]   [Full Text] [Related]  

  • 24. [Long-term results of the treatment of diffuse systemic scleroderma with interferon-gamma].
    Blétry O; Laraki R; Cabane J; Francès C; Piette JC; Soubrier M; Wechsler B; de Gennes C; Valat C; Cosserat J
    Rev Med Interne; 1993; 14(10):978. PubMed ID: 8009071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of oral methotrexate in the treatment of systemic sclerosis.
    Krishna Sumanth M; Sharma VK; Khaitan BK; Kapoor A; Tejasvi T
    Int J Dermatol; 2007 Feb; 46(2):218-23. PubMed ID: 17269983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic sclerosis.
    Ng SC
    Singapore Med J; 1992 Apr; 33(2):189-92. PubMed ID: 1621127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of systemic sclerosis with gamma-interferon.
    Hein R; Behr J; Hündgen M; Hunzelmann N; Meurer M; Braun-Falco O; Urbanski A; Krieg T
    Br J Dermatol; 1992 May; 126(5):496-501. PubMed ID: 1610690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stabilization of Microcirculation in Patients with Early Systemic Sclerosis with Diffuse Skin Involvement following Rituximab Treatment: An Open-label Study.
    Smith V; Pizzorni C; Riccieri V; Decuman S; Brusselle G; DE Pauw M; Deschepper E; Piette Y; Ruaro B; Sulli A; Vandecasteele E; Melsens K; DE Keyser F; Cutolo M
    J Rheumatol; 2016 May; 43(5):995-6. PubMed ID: 27134280
    [No Abstract]   [Full Text] [Related]  

  • 29. Scleroderma in children.
    Zulian F
    Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):576-595. PubMed ID: 29773274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of systemic sclerosis.
    Wigley FM
    Curr Opin Rheumatol; 1992 Dec; 4(6):878-86. PubMed ID: 1457284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical, serological, and immunogenetic studies of systemic sclerosis.
    Maddison PJ
    Rev Rhum Mal Osteoartic; 1991 May; 58(5):369-70. PubMed ID: 1905420
    [No Abstract]   [Full Text] [Related]  

  • 32. Overlap of systemic sclerosis and rheumatoid arthritis.
    Alkassab F
    J Rheumatol; 2007 Jul; 34(7):1593-4. PubMed ID: 17611965
    [No Abstract]   [Full Text] [Related]  

  • 33. Recombinant cytokine treatment for scleroderma. Can the antifibrotic potential of interferon-gamma be realized clinically?
    Varga J
    Arch Dermatol; 1997 May; 133(5):637-42. PubMed ID: 9158418
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of systemic sclerosis].
    van den Hoogen FH
    Z Rheumatol; 2006 Jul; 65(4):306, 308-10. PubMed ID: 16819640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FDA Arthritis Advisory Committee meeting: methotrexate; guidelines for the clinical evaluation of antiinflammatory drugs; DMSO in scleroderma.
    Paulus HE
    Arthritis Rheum; 1986 Oct; 29(10):1289-90. PubMed ID: 3768061
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of methotrexate with placebo in the treatment of systemic sclerosis: a 24 week randomized double-blind trial, followed by a 24 week observational trial.
    van den Hoogen FH; Boerbooms AM; Swaak AJ; Rasker JJ; van Lier HJ; van de Putte LB
    Br J Rheumatol; 1996 Apr; 35(4):364-72. PubMed ID: 8624641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of antimetabolites in diseases of auto-aggression].
    Romiti N
    Hospital (Rio J); 1968 Jan; 73(1):71-8. PubMed ID: 5308511
    [No Abstract]   [Full Text] [Related]  

  • 38. Penile curvature associated with scleroderma.
    Chen TY; Zahran AR; Carrier S
    Urology; 2001 Aug; 58(2):282. PubMed ID: 11489727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Do the interferons have an antifibrotic action? The internist's point of view].
    Blétry O; Somogyi A
    Rev Med Interne; 2002 Nov; 23 Suppl 4():511s-515s. PubMed ID: 12481407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of systemic sclerosis.
    Steen V
    Curr Opin Rheumatol; 1991 Dec; 3(6):979-85. PubMed ID: 1722990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.